Clinical Trial Update: Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for an immunoprophylactic adoptive cellular therapy targeting cytomegalovirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Immunoprophylactic adoptive cellular therapy

Snippet

Sponsor: Cell Medica Ltd | Conditions: Cytomegalovirus Infection | Phase 3 | Status: COMPLETED